Navigation Links
Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
Date:4/19/2013

ruit, motivate and retain qualified personnel, including sales representatives; the possibility that client agreements will be terminated or not renewed; any potential impairment of goodwill or intangible assets; consolidation in the pharmaceutical industry; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing, including initiatives by our clients to perform services we offer internally; our ability to convert backlog into revenue; the potential liability associated with injury to clinical trial participants; the actual impact of the adoption of certain accounting standards; and our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance. Holders of our debt instruments are referred to reports provided to investors from time to time and the offering memoranda provided in connection with the issuance of our notes for further discussion of these risks and other factors.

Media Contact

James Forte
Vice President, Marketing
jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
2. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
3. Alliance to Feed the Future Congratulates Our Farmers, Supports Education for Future Generations on National Agriculture Day
4. The Alliance for Regenerative Medicine forms Tissue Engineering and Biomaterials Committee
5. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
6. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
7. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
8. iBio, Inc. and GE Healthcare form new global alliance
9. Afraxis and PsychoGenics Form Alliance to Offer Afraxis ESP Technology for Drug Discovery
10. Genomind to Participate in National Alliance on Mental Illness (NAMI) 2012 National Convention
11. Clean Energy Alliance and the Manufacturing Extension Partnership Announce New Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 CSL Behring announced today ... for review the company,s Biologics License Application (BLA) for ... the treatment of hemophilia A. In the pivotal clinical ... Hemophilia A is a congenital bleeding disorder ... affected patients are male. People with hemophilia A may ...
(Date:7/28/2015)... July 28, 2015  Faced with increasing challenges ... palliative rather than symptomatic, the global healthcare industry ... therapies capable of curing or significantly changing the ... to look towards regenerative medicine as a viable ... paradigm in human health with the potential to ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a ... provides a basic overview of the industry including definitions, classifications, applications and industry ... development trends, competitive landscape analysis, and key regions development status. Development policies and ...
(Date:7/27/2015)... , July 27, 2015 Research presented at ... will expand on the studies that led to a ... diagnostic for this disease to receive approval from the ... to breaking Ebola,s grip on West Africa ... and enabling healthcare workers to isolate and treat these ...
Breaking Biology Technology:U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... there was one industry list that every company wanted to ... of DEMO and then publisher of PC Letter, the List ... occasions, years) between the time a software product was announced ... time when dozens of new companies were scrambling to put ...
... - To develop a more robust information technology ... according to keynoters at this week's E-Business Best Practices ... technology executives, most notably RedPrairie's John Jazwiec, ... make. But leaders attending the annual E-Business conference did ...
... "break" in Iraq, Matt Storms is ready to continue his ... due diligence and corporate clean up, the mechanics of raising ... Technology Transfer (STTR) grants. We thank Matt for his service, ... entrepreneurs. , , Once you complete your ...
Cached Biology Technology:Is Beta the new Vapor? 2Is Beta the new Vapor? 3Is Beta the new Vapor? 4To drive IT, Wisconsin may need entrepreneurial makeover 2To drive IT, Wisconsin may need entrepreneurial makeover 3Raising capital through placement agents 2Raising capital through placement agents 3Raising capital through placement agents 4
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... Rockville, Md., November 12, 2007 On September 10, ... several multivitamin supplements did not contain label amounts of ... by IVC, Industries, Inc., is part of U. S. ... USP Verified mark. In response to the report, USP ...
... ARTICLE #1 FOR IMMEDIATE RELEASE Toward cancer ... Bioconjugate Chemistry A new drug-delivery system for cancer of ... to treat has the potential to carry anticancer ... researchers in Connecticut and New York report. Their study ...
... Eating too much fructose and glucose can turn off the ... in the body, shows a new study in mice and ... of Clinical Investigation. This discovery reinforces public health advice to ... of glucose and fructose, while fructose is also commonly used ...
Cached Biology News:Market testing of dietary supplements and drugs underscores value of USP's public health programs 2American Chemical Society's Weekly PressPac -- Nov. 7, 2007 2American Chemical Society's Weekly PressPac -- Nov. 7, 2007 3American Chemical Society's Weekly PressPac -- Nov. 7, 2007 4American Chemical Society's Weekly PressPac -- Nov. 7, 2007 5American Chemical Society's Weekly PressPac -- Nov. 7, 2007 6American Chemical Society's Weekly PressPac -- Nov. 7, 2007 7American Chemical Society's Weekly PressPac -- Nov. 7, 2007 8American Chemical Society's Weekly PressPac -- Nov. 7, 2007 9Too much sugar turns off gene that controls the effects of sex steroids 2